SynthesisChinese journal of integrative medicine2024

Benefit-Risk Assessment of Chinese Medicine Injections for Primary Liver Cancer Based on Multi-criteria Decision Analysis.

Rong-Rong Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.